Medicare Enrolled
Dr. Joseph Feliciano, MD
Urology Physician · Allentown, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Feliciano from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Feliciano?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Feliciano
Dr. Joseph Feliciano is an urology physician in Allentown, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Feliciano performed 13,076 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Feliciano received a total of $5,915 from 32 pharmaceutical and/or device companies across 189 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Feliciano is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in PA
$5,915 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,076
Medicare services
Top 1% in PA for urology physician
Not available
Unique patients (not deduplicated)
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 9,100 | $2 | $10 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
978 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
445 | $82 | $210 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 387 | $135 | $514 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
312 | $160 | $420 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
231 | $65 | $230 |
| Injection, garamycin, gentamicin, up to 80 mg | 220 | $2 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
205 | $65 | $146 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
143 | $43 | $88 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
108 | $100 | $255 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
108 | $11 | $65 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
85 | $113 | $317 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
83 | $162 | $460 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
79 | $115 | $290 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
75 | $7 | $55 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
67 | $24 | $70 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
52 | $16 | $65 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
48 | $108 | $1,058 |
| Bladder tumor removal via endoscope This procedure involves using an endoscope to destroy or remove a large growth from the bladder. |
34 | $292 | $1,054 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
33 | $205 | $600 |
| Implantable tissue marker, each A small marker is implanted into tissue to serve as a reference point for future medical imaging or procedures. |
27 | $39 | $609 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
26 | $246 | $500 |
| Bladder/urethra growth removal via endoscope, 0.5-2.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 0.5 and 2.0 centimeters. |
25 | $185 | $510 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
23 | $76 | $280 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
22 | $34 | $155 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
21 | $7 | $120 |
| Biofeedback training for bowel or bladder control, initial 15 minutes A 15-minute session using biofeedback techniques to help patients gain control over bowel or bladder functions. The training involves monitoring physiological processes to learn how to manage muscle activity. |
21 | $59 | $175 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $55 | $175 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
18 | $271 | $1,620 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
18 | $880 | $3,624 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
17 | $2,197 | $7,910 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
17 | $63 | $195 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
16 | $305 | $885 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $102 | $273 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.7% high complexity
5.4% medium
94.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,915
Total received (2018-2024)
Avg $845/year across 7 years
Top 25% in PA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
189
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$167
2023
$511
2022
$378
2021
$938
2020
$503
2019
$2,355
2018
$1,064
Payments by company (2024)
Myriad Genetic Laboratories, Inc.
$147
Photocure Inc
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,179
Astellas Pharma US Inc
$850
Bayer HealthCare Pharmaceuticals Inc.
$442
Janssen Biotech, Inc.
$404
Myriad Genetic Laboratories, Inc.
$340
Bayer Healthcare Pharmaceuticals Inc.
$305
PFIZER INC.
$280
Avadel Specialty Pharmaceuticals, LLC
$272
Photocure Inc
$223
BOSTON SCIENTIFIC CORPORATION
$223
AstraZeneca Pharmaceuticals LP
$198
Myovant Sciences Inc.
$178
KARL STORZ Endoscopy-America
$158
Amniox Medical, Inc.
$153
NeoTract Inc.
$119
Janssen Scientific Affairs, LLC
$100
Blue Earth Diagnostics Limited
$65
Ferring Pharmaceuticals Inc.
$64
Dendreon Pharmaceuticals LLC
$51
Medtronic USA, Inc.
$41
Coloplast Corp
$39
TOLMAR Pharmaceuticals, Inc.
$35
C. R. BARD, INC. & SUBSIDIARIES
$32
Merck Sharp & Dohme Corporation
$29
ABBVIE INC.
$23
UROVANT SCIENCES INC
$19
ROCHESTER MEDICAL CORPORATION
$19
UROGEN PHARMA, INC.
$16
MEDIVATION FIELD SOLUTIONS LLC
$15
Axonics, Inc.
$15
Allergan Inc.
$14
Egalet US Inc
$13
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
16 FR. FLEXIBLE VIDEO CYSTOSCOPE · 16 FR. FLEXIBLE VIDEO CYSTOSCOPE · Axonics r-SNM System · Axumin · BOTOX · BRACANALYSIS CDX · BRACAnalysis CDx · CONTINENCE CARE · CYSVIEW · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL KIDNEY STONE DISEASE · HOPKINS · INTERSTIM · JELMYTO · KEYTRUDA · KS TO SPIES FLEXC · LYNPARZA · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · Prolaris · REZUM · SPACEOAR · SPEEDICATH · SPRIX · TOVIAZ · TRDE UP PROMO · US DEF · UroLift · XTANDI · Xofigo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
47
County median income
$77,493
Nearest hospital to ZIP centroid (approximate)
LEHIGH VALLEY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Feliciano is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Feliciano experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Feliciano performed 9,100 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Feliciano receive payments from pharmaceutical companies?
Yes. Dr. Feliciano received a total of $5,915 from 32 companies across 189 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Feliciano's costs compare to other urology physicians in Allentown?
Dr. Feliciano's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Feliciano) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Allentown
Browse urology physicians in Allentown ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in PA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in PA
Which PA urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology